Glucagon-like peptide-1 signifies a remarkable advance in our control landscape . Originally developed to manage type 2 diabetes , its therapies have revealed a substantial capacity to assist with weight reduction and enhance metabolic well-being . Researchers increasingly investigating these potential in addressing excess weight among patients la